Chronic Disease Management Market Segmentation:
Disease Type Segment Analysis
The cardiovascular diseases segment is estimated to hold the largest share of 30% in the chronic disease management market throughout the discussed years. The growing prevalence of heart failure, coronary artery disease, stroke, and other related illnesses that impact the blood vessels and the heart is positioning this segment as a major revenue generator in this field. According to the World Heart Federation, CVD took away over 20.5 million lives in 2021, making it the leading cause of death globally. In addition, the heightening global population with hypertension, high blood cholesterol, smoking, inactivity, a poor diet, and obesity are highly prone to CVD events and mortality. On this note, a 2022 article revealed that dietary risks alone accounted for 6.5 million CVD deaths in the same year (American College of Cardiology).
Type Segment Analysis
The solutions segment in the chronic disease management market is anticipated to capture a substantial revenue share by 2035. The increased awareness regarding the use and benefits of cloud-based infrastructure in healthcare settings is inflating adoption in this segment. Being a highly desired option to enable patients to share health information for advancing the treatment of chronic diseases, both standalone and hybrid cloud solutions are remarkably contributing to this field’s augmentation. Furthermore, their efficiency in remote monitoring, operational effectiveness, and reduced costs are making them a prior choice for both patients and service providers. For instance, in March 2023, Royal Philips launched Philips Virtual Care Management, offering a cost-effective and comprehensive solution for patient engagement.
Our in-depth analysis of the global chronic disease management market includes the following segments:
|
Type |
|
|
Deployment Mode |
|
|
Disease Type |
|
|
Service Type |
|
|
End user |
|
